1 Br ady HR, Brenner BN, Lieberthal W.Acute renal f ailure.In:Br enner BM, ed.The Kidney.5 th ed.Philadelphia:WB Saunders, 1996:1 200
2 Thadhani R, Pascual M, Bonventre JV.Acute renal f ailure.N Engl J Med, 1996;334:1448
3 Conger JD.Inter ventions in clinical acute renal fail ure:w hat are the data Am J Kidney Dis, 1995, 26: 565
4 Weisberg LS.Kurnik PB.Kurnikh BRC.Risk of radio contrast nephropathy in patients with and without diabetesmellitus.Kidney Int,1994;45:2 59
5 Weinstein JM, Heyman S, Brezis M.Potential deleterious effect of furo semide in radiocontrast nephropathy.Nephon, 1996;62:413
6 Solomon R, Werner C, M ann D, et al.effects of saline, mannitol, and furo semide in radio contrasta-gents.N Eng l J Med, 1994;331:1416
7 Flancbaum L, Choban PS.Dasta JF.Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients.Crit Care Med, 1994;22:61
8 Szerlip HM,.Renal-dose dopamine:fact and fiction, Ann Intern Med, 1991;115:153
9 Baldwin L, Henderson, Hickman P.effect of post-ope ra tiv e low-dose dopamine on renal function after elective major vascular surgery.Ann Intern Med, 1994;120:744
10 Hans B, Hans SS, Mittal VK, et al.Renal function response to dopamine during and after arteriogrphy in pa tien ts with chronicrenal insufficiency.Radiology, 1990;1 76:651
11 Myles PS, Bulkland MK, Schenk NJ.effect of “renal-dose” dopamine on renal function following cardiac surgery.Anaesth Intensive C are, 1993;2 1:56
12 Weisber g LS.Kurnik PS, Kurnik BR.Dopamine and renal blood flow in radiocontra st induced nephropathy in humans.Ren Fail, 1993:1 5:61
13 Thompson BT, Cockrill BA.Rena l-dose dopamine:a siren song Lancet, 1994;334:7
14 Neumayer HH, Kunzendorf U, S ch reibe r M.Pr o-te ctiv e effects of calciumantag onists in human renal transplantation.Kidney Int, 1992;3 6:supplS87
15 Ruggenenti P, Perico N,Mosconi L, et al.Calcium blockers protect transplant patients from cy-clospo rine-induced daily renal hypoperfusion.Kid-ney Int, 1993;43:7 06
16 Ladefoged S D, Andersen CB.Calcium channel blockers in kidney transplantation.Clin Transplant. 1994;8:128
17 Rahman SN, Kim GE, M athew As, et al.effects of atrial nat riuretic peptide in clinical acuterenal failure.Kidney Int, 1994;4 5:1731
18 Hummel M, Kuhn M.Ur odilatin, a new the rapy to prevent kidney failure after heart tr ansplantation.J Hea rt Lung Transplant, 1993;1 2:2 09
19 Allgren R, M arbury TC, Rahman SN, et al.Anar-tide in acute tubular necrosis.N Engl J Med, 1997; 336:8 28
20 Rahman SN, But t AR, DuBose TD, et al.Diffe r-ential clinical effects of anaritide atrial natriuretic peptide in o liguric and non-o liguric ATN.J Am SoC nephr ol, 1995;6:474
21 Humes HD, Acute renal failur e-the promise of new the rapies.N Engl J Med, 1997;336:870
22 Chan L, Chittinandana A, Shapiro JI, et al.Effect of an endothelin receptor antag onist on ischemic acuter enal failure.Am Jphy siol, 1994;2 66:F 135
23 Rogers SA, Miller SB.Hamme rman M R, Tri-iodothy ronine stimulates renal epidermal growth factor expression in adultrat.Am J Physiol, 1995;2 68: F128
24 Franklin S, Moulton M, Hammerman M R, et al. Impro vement of renal function and amelio ration of symptoms in patient s with chronic renal failuret rea ted with insulin-like growth factor-1.J Am Soc Nephro l, 1995;6:3 87
25 Inscho EW., Ohishi K, Cook AK, et al.Calcium activation mechanisms in the renal micro vascula r re-sponse to e x tra cellular ATP.Am J Physiol, 1995: 268:F 876
26 Bonventre JV.M echanisms of ischemic acute r enal failure.Kidney Int, 1993;4 3:1160
27 Jonhson KJ, Weinberg JM.Po stischemic renal in jurydue to oxy gen radicals.Curr opin Nephro l Hy-per tens 1993;2:625
28 HaugCE, Colv in RB, Delminico F L, et al.A pha se1trial of immunosuppr ession with anti-I CAM-1 CCD 54)mAb in r enal allolg raf t recipients.T rans-plantation 1993;5 5:766
29 Baldwin W, Pruitt SK, Brauer RB, et al. Complement in org an transplantation:contributions to inflamma tion, injury, and rejection.Transplantation, 1995;5 9:7 97
30 Eason JD, Pascual M, Wee S, et al.Ev aluation of recombinant human so luble dimeric tumornecrosis factor receptor for prevention of OKT 3-asso ciated a-cute clinical syndr ome.Tr ansplantation, 1996;61: 224
31 How dieshell T R, Blalo ck WE, Bow en PA, et al. Management of post-t raumatic acute r enal failure with peritone al dialy sis.Am Surg, 1992;5 8:378
32 Bellomo R, Parkin G, Love J, et al.Prospective compar ative study of continuous ar te riov enous hemodia filtr ation and continuous veno venous hemodia filtration in criticallyill patients.Am J Kid-ney Dis, 1993;21:4 00
33 Mehta RL.The rapeutic alternatives to renal re-placemen t for criticallyill patients in acute renal failure, Semin Nephrol, 1994;14:64
34 Bellomo R, Tipping P, Boyce N.Continuous v en-o venous hemofiltration with dialysisr emovescy-tokines from the circulation of septic patients.Crit Care Med, 1993;2 1:522
35 Sponsel H, Conger JD.I s pa rente ral nutrition the r-apy of value in acuter enal failure patients Am J Kidney Dis,1995;25:96
36 Combe C, Pour tein M, Precigout V, et al.Granu-locyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux bio-compatible membrane.Am J Kidney Dis, 1994;24: 437
37 Schulman G, Fo go A, Gung A, et al.Complement activation retards resolution of a cute ischemic rena lf ailure in the rat.Kidney Int, 1991;4 0:1069
38 Hakim RM, Clinical implications of hemodialysis membrane biocompa tibility.Kidney Int, 1993;44: 484
39 Pascual M, Schif ferli JA.Adsorption of complement factor D By poly acry lonitrile dialy sis membr anes. Kidney Int, 1993;4 3:903
40 Hakim RM, Wingard RL, Parker RA.effect of the dialy sis membrane in the tr eatment of patients with acute renal failure.N Eng l J Med, 1994;3 31:1 338
41 SchifflH, Lang SM, Konig A, et al.Bioconrpatible membranes in acute renal failure:p rospective case-contro lled study.Lancet, 1994;344:570
42 Pascual M, Tolkoff-Robin N, Schiffe rli JA.I sad-sorption an important characteristic of dialy sismem-branes Kidney Int, 1996;49:3 09 |
